Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357706/
https://www.ncbi.nlm.nih.gov/pubmed/37463792
http://dx.doi.org/10.1136/jitc-2022-006348corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357706/
https://www.ncbi.nlm.nih.gov/pubmed/37463792
http://dx.doi.org/10.1136/jitc-2022-006348corr1

Ejemplares similares